Proceedings: Perhexiline maleate: eighteen months of continuous administration in patients with angina pectoris.
D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000787:Angina Pectoris / Q000188:drug therapy*; D001219:Aspartate Aminotransferases / Q000097:blood; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010480:Perhexiline / Q000008:administration & dosage; D010880:Piperidines / Q000008:administration & dosage*; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage*
D010880:Piperidines; D014665:Vasodilator Agents; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D010480:Perhexiline